Altimmune to Host Virtual R&D Day on March 13, 2025
Provided By GlobeNewswire
Last update: Mar 6, 2025
GAITHERSBURG, M.D., March 06, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that it will host a virtual R&D Day on Thursday, March 13, 2025 beginning at 12:00 pm Eastern Time.
Read more at globenewswire.com
